These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33159980)

  • 21. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
    Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
    J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BDNF Activates Postsynaptic TrkB Receptors to Induce Endocannabinoid Release and Inhibit Presynaptic Calcium Influx at a Calyx-Type Synapse.
    Wu Y; Liu Q; Guo B; Ye F; Ge J; Xue L
    J Neurosci; 2020 Oct; 40(42):8070-8087. PubMed ID: 32948677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation.
    Ohno-Shosaku T; Shosaku J; Tsubokawa H; Kano M
    Eur J Neurosci; 2002 Mar; 15(6):953-61. PubMed ID: 11918654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoids and retrograde modulation of synaptic transmission.
    Ohno-Shosaku T; Tanimura A; Hashimotodani Y; Kano M
    Neuroscientist; 2012 Apr; 18(2):119-32. PubMed ID: 21531987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
    Wallace MJ; Blair RE; Falenski KW; Martin BR; DeLorenzo RJ
    J Pharmacol Exp Ther; 2003 Oct; 307(1):129-37. PubMed ID: 12954810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF; Katona I; Piomelli D
    Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids, endocannabinoids, and cancer.
    Hermanson DJ; Marnett LJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
    Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
    Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex.
    Lemtiri-Chlieh F; Levine ES
    J Neurophysiol; 2010 Oct; 104(4):1923-32. PubMed ID: 20719932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.
    Soltesz I; Alger BE; Kano M; Lee SH; Lovinger DM; Ohno-Shosaku T; Watanabe M
    Nat Rev Neurosci; 2015 May; 16(5):264-77. PubMed ID: 25891509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS.
    Chen CY; Bonham AC; Dean C; Hopp FA; Hillard CJ; Seagard JL
    Auton Neurosci; 2010 Dec; 158(1-2):44-50. PubMed ID: 20580326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CB
    Ji X; Zeng Y; Wu J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.